Clinical Trial Update: K-BASKET, TAS-117, PI3K/AKT Gene Aberration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update (K-BASKET) evaluating TAS-117 targeting PI3K/AKT gene aberrations in solid tumors completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• TAS-117 (TAS-117)

Snippet

Sponsor: Yonsei University | Conditions: Solid Tumor, Adult | Phase 2 | Status: COMPLETED